Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors

被引:166
作者
Hu, CY
Diévart, A
Lupien, M
Calvo, E
Tremblay, G
Jolicoeur, P
机构
[1] Clin Res Inst Montreal, Mol Biol Lab, Montreal, PQ H2W 1R7, Canada
[2] McGill Univ, Dept Pathol, Montreal, PQ, Canada
[3] McGill Univ, Div Expt Med, Montreal, PQ, Canada
[4] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
D O I
10.2353/ajpath.2006.050416
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The mouse mammary tumor virus (MMTV) provirus was found to target the Notch1 gene, producing insertional mutations in mammary tumors of MMTV/ neu transgenic (Tg) mice. In these mammary tumors, the Notch1 gene is truncated upstream of the transmembrane domain, and the resulting Notch1 intracellular domain (Notch1(intra)), deleted of most extracellular sequences, is overexpressed. Although Notch1(intra) transforms mammary epithelial cells in vitro, its role in mammary gland tumor formation in vivo was not studied. Therefore, we generated MMTV/Notch1(intra) Tg mice that overexpress murine Notch1(intra) in the mammary glands. We observed that MMTV/Notch1(intra) Tg females were unable to feed their pups because of impaired ductal and lobulo-alveolar mammary gland development. This was associated with decreased proliferation of ductal and alveolar epithelial cells during rapid expansion at puberty and in early pregnancy, as well as decreased production of beta-casein. Notch1(intra) repressed expression of the beta-casein gene promoter, as assessed in vitro with a beta-casein/luciferase reporter construct. The MMTV/Notch1(intra) Tg females developed mammary gland tumors, confirming the oncogenic potential of Notch1(intra) in vivo. Furthermore, MMTV/ Notch3(intra) Tg mice exhibited a very similar phenotype. Thus, these Tg mice represent novel models for studying the role of Notch1 or Notch3 in the development and transformation of the mammary gland.
引用
收藏
页码:973 / 990
页数:18
相关论文
共 76 条
[1]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[2]  
Beatus P, 1999, DEVELOPMENT, V126, P3925
[3]   Constitutive activation of NF-κB and T-cell leukemia/lymphoma in Notch3 transgenic mice [J].
Bellavia, D ;
Campese, AF ;
Alesse, E ;
Vacca, A ;
Felli, MP ;
Balestri, A ;
Stoppacciaro, A ;
Tiveron, C ;
Tatangelo, L ;
Giovarelli, M ;
Gaetano, C ;
Ruco, L ;
Hoffman, ES ;
Hayday, AC ;
Lendahl, U ;
Frati, L ;
Gulino, A ;
Screpanti, I .
EMBO JOURNAL, 2000, 19 (13) :3337-3348
[4]   Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis [J].
Bellavia, D ;
Campese, AF ;
Checquolo, S ;
Balestri, A ;
Biondi, A ;
Cazzaniga, G ;
Lendahl, U ;
Fehling, HJ ;
Hayday, AC ;
Frati, L ;
von Boehmer, H ;
Gulino, A ;
Screpanti, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3788-3793
[5]   Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines [J].
Bigas, A ;
Martin, DIK ;
Milner, LA .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) :2324-2333
[6]   STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE [J].
BOUCHARD, L ;
LAMARRE, L ;
TREMBLAY, PJ ;
JOLICOEUR, P .
CELL, 1989, 57 (06) :931-936
[7]   Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics [J].
Carlesso, N ;
Aster, JC ;
Sklar, J ;
Scadden, DT .
BLOOD, 1999, 93 (03) :838-848
[8]   EXPRESSION OF AN EXTRACELLULAR DELETION OF XOTCH DIVERTS CELL FATE IN XENOPUS-EMBRYOS [J].
COFFMAN, CR ;
SKOGLUND, P ;
HARRIS, WA ;
KINTNER, CR .
CELL, 1993, 73 (04) :659-671
[9]   Involvement of Notch1 in the development of mouse mammary tumors [J].
Diévart, A ;
Beaulieu, N ;
Jolicoeur, P .
ONCOGENE, 1999, 18 (44) :5973-5981
[10]   XOTCH INHIBITS CELL-DIFFERENTIATION IN THE XENOPUS RETINA [J].
DORSKY, RI ;
RAPAPORT, DH ;
HARRIS, WA .
NEURON, 1995, 14 (03) :487-496